{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Novel+Coronavirus+Infection&page=4", "query": { "condition": "Novel Coronavirus Infection", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 460, "total_pages": 46, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Novel+Coronavirus+Infection&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Novel+Coronavirus+Infection&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-07T00:01:46.129Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05004181", "title": "Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "SARS-CoV-2 Infection", "COVID-19", "SARS-CoV-2 Acute Respiratory Disease", "SARS (Disease)" ], "interventions": [ { "name": "BNT162b2", "type": "BIOLOGICAL" }, { "name": "Multivalent BNT162b2 (B.1.1.7 + B.1.617.2)", "type": "BIOLOGICAL" }, { "name": "Monovalent BNT162b2 (B.1.1.7)", "type": "BIOLOGICAL" }, { "name": "Monovalent BNT162b2 (B.1.617.2)", "type": "BIOLOGICAL" }, { "name": "Monovalent BNT162b2 (B.1.1.529.1)", "type": "BIOLOGICAL" }, { "name": "Observational", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 1380, "start_date": "2021-08-25", "completion_date": "2023-10-04", "has_results": true, "last_update_posted_date": "2024-11-22", "last_synced_at": "2026-10-07T00:01:46.129Z", "location_count": 14, "location_summary": "Long Beach, California • San Diego, California • Milford, Connecticut + 10 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Milford", "state": "Connecticut" }, { "city": "Stamford", "state": "Connecticut" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05004181" }, { "nct_id": "NCT04319731", "title": "A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "SARS CoV-2 Infection" ], "interventions": [ { "name": "Human Amniotic Fluid", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2020-03-20", "completion_date": "2020-06-09", "has_results": false, "last_update_posted_date": "2023-04-24", "last_synced_at": "2026-10-07T00:01:46.129Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04319731" }, { "nct_id": "NCT04381988", "title": "A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "COVID-19", "Cancer" ], "interventions": [ { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "OTHER", "RADIATION" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2020-05-07", "completion_date": "2021-04-21", "has_results": true, "last_update_posted_date": "2021-10-27", "last_synced_at": "2026-10-07T00:01:46.129Z", "location_count": 7, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04381988" }, { "nct_id": "NCT05566483", "title": "Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Post-acute Sequelae of SARS-CoV-2 Infection" ], "interventions": [ { "name": "Exercise", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2023-03-01", "completion_date": "2027-10-31", "has_results": false, "last_update_posted_date": "2025-12-04", "last_synced_at": "2026-10-07T00:01:46.129Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05566483" }, { "nct_id": "NCT05541861", "title": "Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "SARS-CoV-2 Infection", "COVID-19" ], "interventions": [ { "name": "BNT162b2 Bivalent (original/Omicron BA.4/BA.5) 30 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b4 5 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b4 10 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b4 15 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b4 30 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b2 Monovalent (OMI XBB.1.5) 30 mcg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 383, "start_date": "2022-11-08", "completion_date": "2024-11-22", "has_results": true, "last_update_posted_date": "2026-01-13", "last_synced_at": "2026-10-07T00:01:46.129Z", "location_count": 17, "location_summary": "Tempe, Arizona • Newport Beach, California • San Diego, California + 13 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Milford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT05541861" }, { "nct_id": "NCT06999603", "title": "Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Viral Pneumonia" ], "interventions": [ { "name": "SNG001", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Synairgen Research Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2025-09-02", "completion_date": "2026-03-13", "has_results": true, "last_update_posted_date": "2026-09-14", "last_synced_at": "2026-10-07T00:01:46.129Z", "location_count": 5, "location_summary": "Atlanta, Georgia • Chicago, Illinois • Detroit, Michigan + 2 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Toledo", "state": "Ohio" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT06999603" }, { "nct_id": "NCT04169542", "title": "Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Ductal Carcinoma In Situ", "COVID-19 Infection", "Hereditary Breast Carcinoma", "Invasive Breast Carcinoma" ], "interventions": [ { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 600, "start_date": "2019-05-21", "completion_date": "2028-03-31", "has_results": false, "last_update_posted_date": "2026-05-04", "last_synced_at": "2026-10-07T00:01:46.129Z", "location_count": 4, "location_summary": "Conroe, Texas • Houston, Texas • League City, Texas + 1 more", "locations": [ { "city": "Conroe", "state": "Texas" }, { "city": "Houston", "state": "Texas" }, { "city": "League City", "state": "Texas" }, { "city": "Sugar Land", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04169542" }, { "nct_id": "NCT04421664", "title": "Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Corona Virus Infection", "SARS-CoV Infection", "Coronavirus" ], "interventions": [ { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "McGill University Health Centre/Research Institute of the McGill University Health Centre", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 70, "start_date": "2020-03-25", "completion_date": "2020-08-17", "has_results": false, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-10-07T00:01:46.129Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04421664" }, { "nct_id": "NCT04349098", "title": "Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coronavirus Infection" ], "interventions": [ { "name": "Selinexor", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Karyopharm Therapeutics Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 190, "start_date": "2020-04-17", "completion_date": "2020-10-05", "has_results": true, "last_update_posted_date": "2023-01-20", "last_synced_at": "2026-10-07T00:01:46.129Z", "location_count": 20, "location_summary": "Los Angeles, California • Oakland, California • Sacramento, California + 15 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04349098" }, { "nct_id": "NCT04910269", "title": "Outpatient Treatment With Anti-Coronavirus Immunoglobulin", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID", "SARS-CoV2 Infection", "Covid19" ], "interventions": [ { "name": "Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 741, "start_date": "2021-08-06", "completion_date": "2026-06-14", "has_results": false, "last_update_posted_date": "2026-08-13", "last_synced_at": "2026-10-07T00:01:46.129Z", "location_count": 16, "location_summary": "Tucson, Arizona • Mather, California • Palo Alto, California + 13 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Mather", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04910269" } ] }